158 related articles for article (PubMed ID: 20047524)
1. Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study.
Burgos J; Eguiguren N; Quintana E; Cobos P; Centeno Mdel M; Larrieta R; Fernández-Llebrez L
J Perinat Med; 2010; 38(1):23-8. PubMed ID: 20047524
[TBL] [Abstract][Full Text] [Related]
2. The use of atosiban and ritodrine in external cephalic version.
Stergiotou I; Talbot F; Yoong W
Acta Obstet Gynecol Scand; 2007; 86(8):927-9. PubMed ID: 17653876
[TBL] [Abstract][Full Text] [Related]
3. Tocolysis in term breech external cephalic version.
Nor Azlin MI; Haliza H; Mahdy ZA; Anson I; Fahya MN; Jamil MA
Int J Gynaecol Obstet; 2005 Jan; 88(1):5-8. PubMed ID: 15617697
[TBL] [Abstract][Full Text] [Related]
4. Atosiban versus ritodrine as tocolytics in external cephalic version.
Couceiro Naveira E; López Ramón Y Cajal C
J Matern Fetal Neonatal Med; 2022 Jan; 35(1):80-85. PubMed ID: 31931641
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of atosiban for tocolysis during external cephalic version: Systematic review and meta-analysis.
Riemma G; Schiattarella A; La Verde M; Cianci S; Savoia F; De Franciscis P; Cobellis L; Colacurci N; Morlando M
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():86-92. PubMed ID: 33421816
[TBL] [Abstract][Full Text] [Related]
6. Tocolysis for repeat external cephalic version in breech presentation at term: a randomised, double-blinded, placebo-controlled trial.
Impey L; Pandit M
BJOG; 2005 May; 112(5):627-31. PubMed ID: 15842288
[TBL] [Abstract][Full Text] [Related]
7. Does the use of a tocolytic agent affect the success rate of external cephalic version?
Marquette GP; Boucher M; Thériault D; Rinfret D
Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):859-61. PubMed ID: 8885736
[TBL] [Abstract][Full Text] [Related]
8. Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial.
Velzel J; Vlemmix F; Opmeer BC; Molkenboer JF; Verhoeven CJ; van Pampus MG; Papatsonis DN; Bais JM; Vollebregt KC; van der Esch L; Van der Post JA; Mol BW; Kok M
BMJ; 2017 Jan; 356():i6773. PubMed ID: 28126898
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial of acute tocolysis in term labour with atosiban or ritodrine.
de Heus R; Mulder EJ; Derks JB; Kurver PH; van Wolfswinkel L; Visser GH
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):139-45. PubMed ID: 18316155
[TBL] [Abstract][Full Text] [Related]
10. Different effects of tocolytic medication on blood pressure and blood pressure amplification.
Fabry I; De Paepe P; Kips J; Vermeersch S; Van Bortel L
Eur J Clin Pharmacol; 2011 Jan; 67(1):11-7. PubMed ID: 21079937
[TBL] [Abstract][Full Text] [Related]
11. Therapy side-effects and predictive factors for preterm delivery in patients undergoing tocolysis with atosiban or ritodrine for threatened preterm labour.
Driul L; Londero AP; Adorati-Menegato A; Vogrig E; Bertozzi S; Fachechi G; Forzano L; Cacciaguerra G; Perin E; Miceli A; Marchesoni D
J Obstet Gynaecol; 2014 Nov; 34(8):684-9. PubMed ID: 24959721
[TBL] [Abstract][Full Text] [Related]
12. Maternal and perinatal outcomes in external cephalic version: prognostic factors for the success of the technique.
Trobo D; Pintado P; Ortega V; Yllana F; Hernández C; Mendizábal R; De León-Luis J
J Perinat Med; 2019 Sep; 47(7):717-723. PubMed ID: 31369397
[TBL] [Abstract][Full Text] [Related]
13. Employing nifedipine as a tocolytic agent prior to external cephalic version.
Salim R; Zafran N; Nachum Z; Edelstein S; Shalev E
Acta Obstet Gynecol Scand; 2008; 87(4):434-7. PubMed ID: 18382870
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine versus ritodrine during external cephalic version procedure: a case control study.
Levin G; Ezra Y; Weill Y; Kabiri D; Pollack RN; Rottenstreich A
J Matern Fetal Neonatal Med; 2021 Sep; 34(18):3008-3013. PubMed ID: 31608725
[TBL] [Abstract][Full Text] [Related]
15. Atosiban vs ritodrine used prophylactically with cerclage in ICSI pregnancies to prevent pre-term birth in women identified as being at high risk on the basis of transvaginal ultrasound scan.
Locci M; Nazzaro G; Merenda A; Pisaturo ML; Laviscio P; Poppiti R; Miranda M; Stile A; De Placido G
J Obstet Gynaecol; 2006 Jul; 26(5):396-401. PubMed ID: 16846862
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double blind, controlled trial of tocolysis to assist external cephalic version in late pregnancy.
Chung T; Neale E; Lau TK; Rogers M
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):720-4. PubMed ID: 8906005
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.
Moutquin JM; Sherman D; Cohen H; Mohide PT; Hochner-Celnikier D; Fejgin M; Liston RM; Dansereau J; Mazor M; Shalev E; Boucher M; Glezerman M; Zimmer EZ; Rabinovici J
Am J Obstet Gynecol; 2000 May; 182(5):1191-9. PubMed ID: 10819857
[TBL] [Abstract][Full Text] [Related]
18. Sublingual nitroglycerin versus intravenous ritodrine as tocolytic for external cephalic version: a double-blinded randomized trial.
Bujold E; Marquette GP; Ferreira E; Gauthier RJ; Boucher M
Am J Obstet Gynecol; 2003 Jun; 188(6):1454-7; discussion 1457-9. PubMed ID: 12824978
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
20. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.
Goodwin TM; Valenzuela GJ; Silver H; Creasy G
Obstet Gynecol; 1996 Sep; 88(3):331-6. PubMed ID: 8752234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
